drugset / Trial / NCT04270279

Efficacy and Safety of Xueshuanxinmaining Tablet for the Treatment of Stable Angina Pectoris

NCT04270279

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study is a randomized, double-blind, placebo-controlled, parallel clinical trial in Chinese population with stable angina pectoris. The purpose is to determine the efficacy and safety of Xueshuanxinmaining tablet in the treatment of stable angina pectoris.

Timeline

Start
2020-12
Primary completion
2021-08
Completion
2021-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Xueshuanxinmaining tablet Traditional medicine (herbal / TCM) 2 unknown Oral
Background Nitroglycerin Unknown